nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—Cisplatin—bone cancer	0.343	0.63	CbGbCtD
Perindopril—ABCB1—Cisplatin—bone cancer	0.0872	0.16	CbGbCtD
Perindopril—ABCB1—Doxorubicin—bone cancer	0.0584	0.107	CbGbCtD
Perindopril—ABCB1—Methotrexate—bone cancer	0.0566	0.104	CbGbCtD
Perindopril—Urinary tract disorder—Methotrexate—bone cancer	0.000683	0.0015	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—bone cancer	0.000683	0.0015	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—bone cancer	0.000682	0.0015	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—bone cancer	0.00068	0.0015	CcSEcCtD
Perindopril—Urethral disorder—Methotrexate—bone cancer	0.000678	0.00149	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—bone cancer	0.000676	0.00149	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—bone cancer	0.000673	0.00148	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—bone cancer	0.000671	0.00148	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—bone cancer	0.000667	0.00147	CcSEcCtD
Perindopril—Visual impairment—Methotrexate—bone cancer	0.000666	0.00147	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000661	0.00145	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—bone cancer	0.000659	0.00145	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—bone cancer	0.000656	0.00144	CcSEcCtD
Perindopril—Erythema multiforme—Methotrexate—bone cancer	0.000654	0.00144	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—bone cancer	0.00065	0.00143	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—bone cancer	0.00065	0.00143	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—bone cancer	0.00065	0.00143	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—bone cancer	0.000649	0.00143	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—bone cancer	0.000648	0.00143	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—bone cancer	0.000648	0.00143	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—bone cancer	0.000647	0.00142	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—bone cancer	0.000647	0.00142	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—bone cancer	0.000646	0.00142	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—bone cancer	0.000645	0.00142	CcSEcCtD
Perindopril—Asthenia—Cisplatin—bone cancer	0.000642	0.00141	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—bone cancer	0.000642	0.00141	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—bone cancer	0.000642	0.00141	CcSEcCtD
Perindopril—Sweating—Doxorubicin—bone cancer	0.000639	0.00141	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—bone cancer	0.000639	0.00141	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—bone cancer	0.000637	0.0014	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—bone cancer	0.000636	0.0014	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—bone cancer	0.000634	0.0014	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—bone cancer	0.000631	0.00139	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—bone cancer	0.000629	0.00138	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—bone cancer	0.000627	0.00138	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—bone cancer	0.000626	0.00138	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—bone cancer	0.000624	0.00137	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—bone cancer	0.000623	0.00137	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—bone cancer	0.000622	0.00137	CcSEcCtD
Perindopril—Chills—Methotrexate—bone cancer	0.00062	0.00136	CcSEcCtD
Perindopril—Diarrhoea—Cisplatin—bone cancer	0.000613	0.00135	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—bone cancer	0.000612	0.00135	CcSEcCtD
Perindopril—Alopecia—Methotrexate—bone cancer	0.000611	0.00134	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—bone cancer	0.00061	0.00134	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—bone cancer	0.000606	0.00133	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—bone cancer	0.000605	0.00133	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—bone cancer	0.000603	0.00133	CcSEcCtD
Perindopril—Erythema—Methotrexate—bone cancer	0.000602	0.00132	CcSEcCtD
Perindopril—Malnutrition—Methotrexate—bone cancer	0.000602	0.00132	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—bone cancer	0.000602	0.00132	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—bone cancer	0.000601	0.00132	CcSEcCtD
Perindopril—Flushing—Epirubicin—bone cancer	0.000601	0.00132	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—bone cancer	0.0006	0.00132	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—bone cancer	0.000599	0.00132	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—bone cancer	0.000599	0.00132	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—bone cancer	0.000594	0.00131	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—bone cancer	0.000591	0.0013	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—bone cancer	0.00059	0.0013	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—bone cancer	0.000589	0.0013	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—bone cancer	0.000587	0.00129	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—bone cancer	0.000587	0.00129	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—bone cancer	0.000583	0.00128	CcSEcCtD
Perindopril—Back pain—Methotrexate—bone cancer	0.000582	0.00128	CcSEcCtD
Perindopril—Chills—Epirubicin—bone cancer	0.000581	0.00128	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—bone cancer	0.000578	0.00127	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—bone cancer	0.000577	0.00127	CcSEcCtD
Perindopril—Alopecia—Epirubicin—bone cancer	0.000572	0.00126	CcSEcCtD
Perindopril—Vomiting—Cisplatin—bone cancer	0.000569	0.00125	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—bone cancer	0.000567	0.00125	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—bone cancer	0.000566	0.00125	CcSEcCtD
Perindopril—Rash—Cisplatin—bone cancer	0.000564	0.00124	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—bone cancer	0.000564	0.00124	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—bone cancer	0.000563	0.00124	CcSEcCtD
Perindopril—Erythema—Epirubicin—bone cancer	0.000563	0.00124	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—bone cancer	0.00056	0.00123	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—bone cancer	0.000558	0.00123	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—bone cancer	0.000558	0.00123	CcSEcCtD
Perindopril—Anaemia—Methotrexate—bone cancer	0.000556	0.00122	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—bone cancer	0.000556	0.00122	CcSEcCtD
Perindopril—Flushing—Doxorubicin—bone cancer	0.000556	0.00122	CcSEcCtD
Perindopril—Flatulence—Epirubicin—bone cancer	0.000555	0.00122	CcSEcCtD
Perindopril—Tension—Epirubicin—bone cancer	0.000553	0.00122	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—bone cancer	0.000552	0.00121	CcSEcCtD
Perindopril—Nervousness—Epirubicin—bone cancer	0.000547	0.0012	CcSEcCtD
Perindopril—Back pain—Epirubicin—bone cancer	0.000545	0.0012	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—bone cancer	0.000543	0.0012	CcSEcCtD
Perindopril—Malaise—Methotrexate—bone cancer	0.000543	0.00119	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—bone cancer	0.000542	0.00119	CcSEcCtD
Perindopril—Vertigo—Methotrexate—bone cancer	0.000541	0.00119	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—bone cancer	0.00054	0.00119	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—bone cancer	0.000539	0.00119	CcSEcCtD
Perindopril—Chills—Doxorubicin—bone cancer	0.000537	0.00118	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—bone cancer	0.000535	0.00118	CcSEcCtD
Perindopril—Nausea—Cisplatin—bone cancer	0.000532	0.00117	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—bone cancer	0.000529	0.00116	CcSEcCtD
Perindopril—Cough—Methotrexate—bone cancer	0.000525	0.00116	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—bone cancer	0.000525	0.00115	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—bone cancer	0.000523	0.00115	CcSEcCtD
Perindopril—Erythema—Doxorubicin—bone cancer	0.000521	0.00115	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—bone cancer	0.000521	0.00115	CcSEcCtD
Perindopril—Anaemia—Epirubicin—bone cancer	0.000521	0.00115	CcSEcCtD
Perindopril—Agitation—Epirubicin—bone cancer	0.000518	0.00114	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—bone cancer	0.000514	0.00113	CcSEcCtD
Perindopril—Myalgia—Methotrexate—bone cancer	0.000512	0.00113	CcSEcCtD
Perindopril—Chest pain—Methotrexate—bone cancer	0.000512	0.00113	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—bone cancer	0.000512	0.00113	CcSEcCtD
Perindopril—Tension—Doxorubicin—bone cancer	0.000511	0.00113	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—bone cancer	0.00051	0.00112	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000509	0.00112	CcSEcCtD
Perindopril—Malaise—Epirubicin—bone cancer	0.000508	0.00112	CcSEcCtD
Perindopril—Discomfort—Methotrexate—bone cancer	0.000506	0.00111	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—bone cancer	0.000506	0.00111	CcSEcCtD
Perindopril—Vertigo—Epirubicin—bone cancer	0.000506	0.00111	CcSEcCtD
Perindopril—Syncope—Epirubicin—bone cancer	0.000505	0.00111	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—bone cancer	0.000504	0.00111	CcSEcCtD
Perindopril—Back pain—Doxorubicin—bone cancer	0.000504	0.00111	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—bone cancer	0.000501	0.0011	CcSEcCtD
Perindopril—Palpitations—Epirubicin—bone cancer	0.000498	0.0011	CcSEcCtD
Perindopril—Confusional state—Methotrexate—bone cancer	0.000495	0.00109	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—bone cancer	0.000495	0.00109	CcSEcCtD
Perindopril—Cough—Epirubicin—bone cancer	0.000492	0.00108	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—bone cancer	0.000491	0.00108	CcSEcCtD
Perindopril—Hypertension—Epirubicin—bone cancer	0.000486	0.00107	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—bone cancer	0.000484	0.00106	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—bone cancer	0.000482	0.00106	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—bone cancer	0.000482	0.00106	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—bone cancer	0.000481	0.00106	CcSEcCtD
Perindopril—Myalgia—Epirubicin—bone cancer	0.00048	0.00106	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—bone cancer	0.00048	0.00106	CcSEcCtD
Perindopril—Chest pain—Epirubicin—bone cancer	0.00048	0.00106	CcSEcCtD
Perindopril—Agitation—Doxorubicin—bone cancer	0.000479	0.00105	CcSEcCtD
Perindopril—Anxiety—Epirubicin—bone cancer	0.000478	0.00105	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—bone cancer	0.000477	0.00105	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000476	0.00105	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—bone cancer	0.000475	0.00104	CcSEcCtD
Perindopril—Discomfort—Epirubicin—bone cancer	0.000474	0.00104	CcSEcCtD
Perindopril—Malaise—Doxorubicin—bone cancer	0.00047	0.00103	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—bone cancer	0.000469	0.00103	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—bone cancer	0.000468	0.00103	CcSEcCtD
Perindopril—Anorexia—Methotrexate—bone cancer	0.000468	0.00103	CcSEcCtD
Perindopril—Syncope—Doxorubicin—bone cancer	0.000467	0.00103	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—bone cancer	0.000467	0.00103	CcSEcCtD
Perindopril—Confusional state—Epirubicin—bone cancer	0.000464	0.00102	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—bone cancer	0.000461	0.00101	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—bone cancer	0.00046	0.00101	CcSEcCtD
Perindopril—Oedema—Epirubicin—bone cancer	0.00046	0.00101	CcSEcCtD
Perindopril—Hypotension—Methotrexate—bone cancer	0.000459	0.00101	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—bone cancer	0.000458	0.00101	CcSEcCtD
Perindopril—Cough—Doxorubicin—bone cancer	0.000455	0.001	CcSEcCtD
Perindopril—Shock—Epirubicin—bone cancer	0.000452	0.000995	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—bone cancer	0.000451	0.000992	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—bone cancer	0.00045	0.00099	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—bone cancer	0.00045	0.00099	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—bone cancer	0.000449	0.000987	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000448	0.000985	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—bone cancer	0.000447	0.000982	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—bone cancer	0.000444	0.000978	CcSEcCtD
Perindopril—Insomnia—Methotrexate—bone cancer	0.000444	0.000978	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—bone cancer	0.000444	0.000976	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—bone cancer	0.000444	0.000976	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—bone cancer	0.000444	0.000976	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—bone cancer	0.000442	0.000973	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—bone cancer	0.000441	0.00097	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000441	0.00097	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—bone cancer	0.000438	0.000965	CcSEcCtD
Perindopril—Anorexia—Epirubicin—bone cancer	0.000438	0.000964	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—bone cancer	0.000438	0.000964	CcSEcCtD
Perindopril—Somnolence—Methotrexate—bone cancer	0.000437	0.000961	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—bone cancer	0.000434	0.000955	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—bone cancer	0.000432	0.000951	CcSEcCtD
Perindopril—Hypotension—Epirubicin—bone cancer	0.00043	0.000945	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—bone cancer	0.000429	0.000944	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—bone cancer	0.000427	0.00094	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—bone cancer	0.000425	0.000936	CcSEcCtD
Perindopril—Oedema—Doxorubicin—bone cancer	0.000425	0.000936	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—bone cancer	0.000424	0.000933	CcSEcCtD
Perindopril—Fatigue—Methotrexate—bone cancer	0.000424	0.000932	CcSEcCtD
Perindopril—Pain—Methotrexate—bone cancer	0.00042	0.000924	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000419	0.000921	CcSEcCtD
Perindopril—Shock—Doxorubicin—bone cancer	0.000419	0.000921	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—bone cancer	0.000417	0.000918	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—bone cancer	0.000416	0.000916	CcSEcCtD
Perindopril—Insomnia—Epirubicin—bone cancer	0.000416	0.000915	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—bone cancer	0.000415	0.000913	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—bone cancer	0.000413	0.000909	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—bone cancer	0.000413	0.000908	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—bone cancer	0.000411	0.000905	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—bone cancer	0.00041	0.000902	CcSEcCtD
Perindopril—Somnolence—Epirubicin—bone cancer	0.000409	0.000899	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—bone cancer	0.000405	0.000892	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—bone cancer	0.000405	0.000891	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—bone cancer	0.000405	0.00089	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—bone cancer	0.000402	0.000884	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—bone cancer	0.0004	0.000879	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—bone cancer	0.000397	0.000874	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—bone cancer	0.000397	0.000873	CcSEcCtD
Perindopril—Fatigue—Epirubicin—bone cancer	0.000396	0.000872	CcSEcCtD
Perindopril—Pain—Epirubicin—bone cancer	0.000393	0.000865	CcSEcCtD
Perindopril—Constipation—Epirubicin—bone cancer	0.000393	0.000865	CcSEcCtD
Perindopril—Urticaria—Methotrexate—bone cancer	0.00039	0.000859	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—bone cancer	0.000388	0.000854	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—bone cancer	0.000388	0.000854	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000388	0.000853	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—bone cancer	0.000385	0.000846	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—bone cancer	0.000382	0.00084	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—bone cancer	0.000379	0.000834	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—bone cancer	0.000379	0.000833	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—bone cancer	0.000378	0.000832	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—bone cancer	0.000376	0.000827	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—bone cancer	0.000374	0.000824	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—bone cancer	0.00037	0.000814	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000367	0.000808	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—bone cancer	0.000367	0.000807	CcSEcCtD
Perindopril—Urticaria—Epirubicin—bone cancer	0.000365	0.000804	CcSEcCtD
Perindopril—Pain—Doxorubicin—bone cancer	0.000364	0.0008	CcSEcCtD
Perindopril—Constipation—Doxorubicin—bone cancer	0.000364	0.0008	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—bone cancer	0.000363	0.0008	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—bone cancer	0.000363	0.0008	CcSEcCtD
Perindopril—Asthenia—Methotrexate—bone cancer	0.000352	0.000775	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—bone cancer	0.000351	0.000771	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000348	0.000765	CcSEcCtD
Perindopril—Pruritus—Methotrexate—bone cancer	0.000348	0.000765	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—bone cancer	0.000338	0.000743	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—bone cancer	0.000336	0.00074	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—bone cancer	0.000336	0.00074	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—bone cancer	0.000336	0.000739	CcSEcCtD
Perindopril—Asthenia—Epirubicin—bone cancer	0.00033	0.000726	CcSEcCtD
Perindopril—Pruritus—Epirubicin—bone cancer	0.000325	0.000716	CcSEcCtD
Perindopril—Dizziness—Methotrexate—bone cancer	0.000325	0.000715	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—bone cancer	0.000315	0.000692	CcSEcCtD
Perindopril—Vomiting—Methotrexate—bone cancer	0.000312	0.000687	CcSEcCtD
Perindopril—Rash—Methotrexate—bone cancer	0.00031	0.000681	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—bone cancer	0.000309	0.000681	CcSEcCtD
Perindopril—Headache—Methotrexate—bone cancer	0.000308	0.000677	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—bone cancer	0.000305	0.000671	CcSEcCtD
Perindopril—Dizziness—Epirubicin—bone cancer	0.000304	0.000669	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—bone cancer	0.000301	0.000662	CcSEcCtD
Perindopril—Vomiting—Epirubicin—bone cancer	0.000292	0.000643	CcSEcCtD
Perindopril—Nausea—Methotrexate—bone cancer	0.000292	0.000642	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—bone cancer	0.000291	0.00064	CcSEcCtD
Perindopril—Rash—Epirubicin—bone cancer	0.00029	0.000638	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—bone cancer	0.00029	0.000637	CcSEcCtD
Perindopril—Headache—Epirubicin—bone cancer	0.000288	0.000634	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—bone cancer	0.000281	0.000619	CcSEcCtD
Perindopril—Nausea—Epirubicin—bone cancer	0.000273	0.000601	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—bone cancer	0.00027	0.000595	CcSEcCtD
Perindopril—Rash—Doxorubicin—bone cancer	0.000268	0.00059	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—bone cancer	0.000268	0.00059	CcSEcCtD
Perindopril—Headache—Doxorubicin—bone cancer	0.000266	0.000586	CcSEcCtD
Perindopril—Nausea—Doxorubicin—bone cancer	0.000253	0.000556	CcSEcCtD
